Changeflow GovPing Pharma & Drug Safety Multivalent Trident Aptamers for Molecular Reco...
Priority review Rule Added Final

Multivalent Trident Aptamers for Molecular Recognition

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

The USPTO published patent application US20260098270A1 by McMaster University on April 9, 2026. The application covers multivalent trident aptamers comprising a branched linker molecule with 2-3 variable arms connected to a root, designed for enhanced affinity and avidity in target molecular recognition. The aptamers have applications in pharmaceutical, diagnostic, and therapeutic fields.

What changed

The USPTO published McMaster University's patent application for multivalent trident aptamers, a novel molecular recognition technology using a central branched linker structure with 2-3 variable arms and a root component, designed to provide enhanced affinity and avidity for target binding.

Affected parties including competitors, researchers, and companies developing aptamer-based products should monitor this application as it represents potential prior art in the aptamer space. The broad applications in pharmaceutical, diagnostic, and therapeutic fields may affect freedom-to-operate considerations.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 11, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

MULTIVALENT TRIDENT APTAMERS FOR MOLECULAR RECOGNITION, METHODS OF MAKING AND USES THEREOF

Application US20260098270A1 Kind: A1 Apr 09, 2026

Assignee

MCMASTER UNIVERSITY

Inventors

Yingfu LI, John BRENNAN, Jiuxing LI, Zijie ZHANG, Jimmy GU, Ryan AMINI, Alexandria MANSFIELD, Jianrun XIA, Dawn WHITE, Hannah D. STACEY, Jann C. ANG, Gurpreet PANESAR, Alfredo CAPRETTA, Carlos FILIPE, Karen MOSSMAN, Bruno J. SALENA, Cynthia BALION, Leyla SOLEYMANI, Matthew S. MILLER, Deborah YAMAMURA, Sam AFKHAMI, Michael Rein D'AGOSTINO

Abstract

Multivalent trident aptamers comprising the general formula [A-SA]2 or 3-L-[SB-B] in which a central branched linker molecule (L) possesses 2 or 3 variable arms ([A-SA]2 or 3), and a root ([SB-B]), connected by a central carbon atom, to provide enhanced affinity and/or avidity with a target are described, as well as methods of making and using the multivalent trident aptamers are provided.

CPC Classifications

C12N 15/115 A61K 9/0043 A61K 31/7088 A61P 31/16 C12N 15/1131 C12Q 1/68 C12Q 1/701 C12N 2310/16 C12N 2310/51

Filing Date

2023-09-22

Application No.

19113866

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260098270A1

Who this affects

Applies to
Pharmaceutical companies Medical device makers Researchers
Industry sector
3254.1 Biotechnology 3254 Pharmaceutical Manufacturing
Activity scope
Patent application Molecular recognition technology Biotech research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Pharmaceuticals Scientific Research

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!